Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 28;4(8):1340-1342.
doi: 10.1002/rth2.12444. eCollection 2020 Nov.

A hematologic support score for longitudinal measurement of blood and iron requirements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders

Hanny Al-Samkari  1 , Rakhi P Naik  2 , Neil A Zakai  3
Affiliations

A hematologic support score for longitudinal measurement of blood and iron requirements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders

Hanny Al-Samkari et al. Res Pract Thromb Haemost. .
No abstract available

Keywords: HHT; Osler‐Weber‐Rendu; blood transfusion; clinical trials; hereditary hemorrhagic telangiectasia; intravenous iron.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Hematologic Support Score (HSS). Fe, iron; RBCs, red blood cells
See this image and copyright information in PMC

References

    1. Kritharis A, Al‐Samkari H, Kuter DJ. Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective. Haematologica. 2018;103:1433–43. - PMC - PubMed
    1. Kasthuri RS, Montifar M, Nelson J, Kim H, Lawton MT, Faughnan ME. Brain Vascular Malformation Consortium HHTIG. Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia. Am J Hematol. 2017;92(10):E591–E593. - PMC - PubMed
    1. Al‐Samkari H, Kasthuri RS, Parambil JG, Albitar HA, Almodallal YA, Vazquez C, et al. An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT‐Bleed study. Haematologica. 2020. 10.3324/haematol.2020.261859 [Epub ahead of print]. - DOI - PMC - PubMed
    1. Al‐Samkari H, Albitar HA, Olitsky SE, Clancy MS, Iyer VN. An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia. Haemophilia. 2020. 10.1111/hae.14140 [Epub ahead of print]. - DOI - PubMed
    1. Al‐Samkari H, Albitar HA, Olitsky SE, Clancy MS, Iyer VN. Systemic bevacizumab for high‐output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers. Orphanet J Rare Dis. 2019;14:256. - PMC - PubMed

LinkOut - more resources